Never miss another update

Subscribe Today!

Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma

Orphan Designation Granted by EMA to MTX110 Development for the Treatment of Glioma ABINGDON, NR / ACCESSWIRE / June 21, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce that following the submission of an application to the European Medicines Agency… Read More »Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma

The post Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma appeared on Stocks News Feed.

Posted in

The Markets Today